VIVIMUSTA

Azurity Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 28, 2025
Approval ID: 4df6548f-c4ad-4eb2-a54f-19766a3d90ca
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use VIVIMUSTA safely and effectively. See full prescribing information for VIVIMUSTA. VIVIMUSTA® (bendamustine hydrochloride injection), for intravenous use. Initial U.S. Approval: 2008

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.